Grupo Casa Saba, S.A. (ADR)  

(Public, NYSE:SAB)   Watch this stock  
7.12
0.00 (0.00%)
Aug 1 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 6.36 - 16.00
Open     -
Vol / Avg. 0.00/381.00
Mkt cap 188.98M
P/E 23.06
Div/yield     -
EPS 0.31
Shares 26.54M
Beta 0.81
Inst. own 5%
Aug 17, 2012
Grupo Casa Saba SA de CV Ordinary & Extraordinary Shareholder Meeting - 1:00PM EDT - Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '11) 2011
Net profit margin -2.47% 0.19%
Operating margin 4.55% 3.07%
EBITD margin - 4.04%
Return on average assets -2.88% 0.28%
Return on average equity -11.09% 1.58%
Employees 19,702 -
Carbon Disclosure Rating - -

Address

Paseo de la Reforma 215 Col. Lomas de Chapultepec
MEXICO, D.F., 11000
Mexico
+52-55-52846600 (Phone)
+52-55-52846633 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Grupo Casa Saba, S.A.B. de C.V. (Grupo Casa Saba) is a holding company that conducts substantially all of its operations through subsidiaries. The Company is a multi-channel, multi-product national wholesale distributor in Mexico. It distributes pharmaceutical products, health, beauty aids and consumer goods, general merchandise, publications and other products. The Company operates in two segments: the distribution segment and retail pharmacy segment. In the Company�s Distribution Division, it distributes over 15,000 products, including 6,400 pharmaceutical products; 6,400 pharmaceutical products; 700 general merchandise and other products, such as food and toiletries, and 3,000 publications. It is a pharmacy retailer in Latin America. On January 19, 2012, FASA Investment Limitada, a subsidiary of Grupo Casa Saba, sold its interest in Famacias Peruanas, S.A. and Drogueria La Victoria, S.A.C., subsidiary companies of Farmacias Ahumada, S.A. (FASA).

Officers and directors

Enrique Castillo Sanchez-Mejorada Co-Chairman of the Board, Independent Director
Age: 55
Bio & Compensation - Reuters
Manuel Saba Ades Co-Chairman of the Board
Age: 44
Bio & Compensation - Reuters
Gabriel Saba D'jamus Chief Executive Officer, Director
Age: 42
Bio & Compensation - Reuters
Miguel Aleman Magnani President, Independent Director
Age: 46
Bio & Compensation - Reuters
Alberto Saba Ades Vice Chairman of the Board
Age: 46
Bio & Compensation - Reuters
Jorge Manuel Sanchez Lanzilotti Director of Strategic Planning and Finance
Age: 42
Bio & Compensation - Reuters
Pedro Canton y Figueroa Director of Operations and Sales, Southern Region
Age: 62
Bio & Compensation - Reuters
Hector Manzano de la Torre Director of Operations and Sales, Northern Region
Age: 45
Bio & Compensation - Reuters
Pedro Alejandro Sadurni Gomez Executive Vice President of Pharmacy Division, Director
Age: 52
Bio & Compensation - Reuters
Juan Carlos Peralta del Rio Vice President, Independent Director
Age: 36
Bio & Compensation - Reuters